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Background: The biological mechanisms involved in non-contact musculoskeletal soft tissue injuries (NCMSTI) are
poorly understood. Genetic risk factors may be associated with susceptibility to injuries, and may exert marked
influence on recovery times.
Methods: Data on type and degree of injury and recovery time were collected in 73 male professional soccer
players (43 White, 11 Black Africans and 19 Hispanics) who suffered total of 242 injuries (203 muscle, 24 ligament,
and 15 tendon injuries). One single nucleotide polymorphism (SNPs) in the following genes were analyzed: Elastin
(ELN); Titin (TTN); SRY-related HMG-box (SOX15); Insulin-like growth factor 2 (IGF2); Chemokine, CC motif, ligand
2 (CCL2); Collagen type 1 alpha 1(COL1A1); Collagen type 5 alpha 1 (COL5A1), and Tenascin C (TNC).
Results: There was evidence of a statistically significant association between the degree of injury and the IGF2
genotype (P = 0.034). In addition, there was evidence of a statistically significant association between the degree of
muscle injury and CCL2 (P = 0.026) Finally, there was evidence of a statistically significant association between ELN
and degree of injury (p = 0.009) and recovery time (P = 0.043). There was no evidence of a statistically significant
association between any of the genes studied and degree of injury or recovery time for tendon injuries.
Conclusion: SNPs in the IGF2, CCL2, and ELN genes may be associated to the degree and recovery time
of NCMSTI.
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The interaction between extrinsic and intrinsic factors,
including genetic risk factors, is crucial to assessing
causation in non-contact soft musculoskeletal tissue
injuries (NCSMTIs) [1-3]. Careful epidemiological stud-
ies are currently the main and most reliable source of
objective knowledge on predisposition to injuries [4-8].
However, few well designed studies have investigated the
aetiology of muscle, ligament and tendon injuries [9]. To* Correspondence: n.maffulli@qmul.ac.uk
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reproduction in any medium, provided the ordate, there is no conclusive scientific evidence to identify
risk factors for NCSMTIs, or to explain interindividual
differences in recovery times, although recent studies
have identified genetic risk factors in the pathogenesis of
NCSMTIs [2,10-13].
A single nucleotide polymorphism (SNP) is a DNA se-
quence variation which occurs when a single nucleotide in
the genome or other shared sequence differs between mem-
bers of a species or between paired chromosomes in a given
individual. SNPs can occur throughout the genome, both in
coding and non-coding regions, and can affect the response
of an individual to a specific treatment or other stimuli.
SNPs in genes related to the biology of muscles, [14,15] ten-
dons [16-18] and ligaments [19] have been associated withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics and functions of the SNPs
included in the study
Gene Related function rsNCBI
ELN [22] Tissue repair rs2289360
TTN [24] Muscle assembly rs2742327
Force transmission
SOX15 [25] Skeletal muscle regeneration rs4227
IGF2 [26] Muscle damage rs3213221
CCL2 [27] Response to muscle damage rs2857656
TNC [10] Tendinopathy rs2104772
COL1A1 [28] Ligament ruptures rs1800012
COL5A1 [28] Ligament ruptures rs12722
Tendinopathy
The numbers in brackets are the relevant references.
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been related to tissue repair (elastin [ELN]) [22,23], muscle
assembly and force transmission (titin [TTN]) [24], skeletal
muscle regeneration (SRY-related HMG-box [SOX15]) [25],
muscle damage (insulin-like growth factor 2 [IGF2]) [26],
response to muscle damage (chemokine, CC motif, ligand 2
[CCL2]) [27], ligament ruptures ([COL1A1] and collagen
type 5 alpha 1[COL5A1]) [28], and tendinopathy (COL5A1
and tenascin [TNC]) [10,29].
The present study investigated the association of SNPs
in these eight genes in a population of professional soc-
cer players from an elite European soccer club to deter-
mine the potential relationship between these SNPs and
degree of injury and recovery time.
Methods
The study was approved by the Ethics Committee of the
Hospital Clinic, Barcelona (registry no. 2012/7117), and
all players gave their signed informed consent.
Population and types of injuries
Data were collected on injuries suffered by 73 elite soccer
players from Futbol Club Barcelona (Barcelona, Catalunya,
Spain) over the course of three consecutive soccer seasons.
All the players included in the study, either from the first
(n = 49) and the second team (n = 26) lived within 30 km of
the training field, and were thus subjected to the same
climate and environmental conditions. All the players
undertook similar amount of work, followed similar diet
(data not available), and took the same ergogenic aids. The
training field, the playing fields and the injury prevention
protocols were also identical for all the players. The treat-
ment protocol for each type of injury, including medication
and physical therapy, was the same for all the players, and
all treatment was supervised by the same medical team.
Given the high qualification level of the study popula-
tion (73 male professional soccer players from the same
football team) and based on the sample size (n = 242) of
the NCSMTIs encountered, we decided to study the most
common injury in each tissue group, i.e. hamstring injuries
for muscle injuries, patellar tendon injuries for tendon in-
juries, and medial collateral ligament injuries for ligament
injuries. Data on injuries were collected in accordance
with the Union of European Football Associations (UEFA)
protocol [30]. Ultrasound and magnetic resonance im-
aging scans were used to morphologically classify the in-
juries by anatomic region. Injuries were classified as mild,
moderate or severe [31] according to the number of days
that a player needed to be absent from training and/or
competition [32,33]: mild, 1–15 days; moderate, 16–30
days; and severe, more than 30 days. A mild lesion presents
minimal tissue damage (up to 25%), a moderate injury in-
volves 50% of the tissue and, finally, in a serious injury
more than 50% of the tissue is involved. Recovery time wasdefined as the time from the date of injury until the date
the player could return to full training or competition.
DNA extraction and genotyping
Approximately 4 mL of whole blood was collected from
each subject into EDTA vacutainer tubes, and stored at
4°C until total DNA extraction. Genomic DNA from whole
blood was isolated using QIAmp DNA Blood Minikit
(Qiagen, Valencia, CA) following the manufacturer’s in-
structions. To measure DNA quantity, a NanoDrop ND-
1000 Spectrophotometer (Thermo Fisher Scientific INC,
Waltham, MA) was used. DNA was stored at −20°C until
analysed.
Table 1 shows the characteristics of all the SNPs ana-
lyzed. Primers and probes were obtained from Applied
Biosystems (AB; Assays-on-Demand SNP genotyping
product, Foster City, CA).
SNP analysis was performed using a real-time polymerase
chain reaction (PCR) Allelic Discrimination TaqMan Assay
(AB) with minor modifications. All PCR reactions were run
in duplicate, and contained 50 ng of each individual’s DNA;
6.25 μL TaqMan Universal Master Mix (AB); 0.25 μL
primers and probes (AB) and water for a final volume of
12.5 μL. Real-time PCR was performed on an ABIPrism
7500 Sequence Detection System (AB) using the following
conditions: 50°C for 2 minutes, 95°C for 10 minutes, and
40 cycles of amplification (95°C for 15 seconds and 60°C
for 1 minute). For each cycle, the software determined the
fluorescent signal from the VIC- or FAM- labeled probe.
Statistical analyses
Descriptive statistics of the main demographic variables
of the studied population (mean, standard deviation, or
median, range, for continuous data, and frequency tables
for specific data) was calculated. Frequency tables were
used for the distribution of the SNPs for the different
genes evaluated.
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the SNPs (in ELN, TTN, SOX15, IGF2, CCL2, COL1A1,
COL5A1 and TNC) was determined with the Chi-square
test and Fisher’s exact test when necessary. The associ-
ation between SNPs and injury recovery time was evalu-
ated using multivariate analysis of variance. All statistical
analyses were performed using SPSS version 14.0 for Win-
dows (SPSS Inc., Chicago, IL). Significance was set at P ≤
0.05. The Benjamini-Hochberg P-value corrective test for
multiple comparisons was applied.
Results
Study population
Of the 73 soccer players included in the study, 43
(58.9%) were White, 11 (15.1%) were Black Africans,
and 19 (26%) were Hispanics. The median age for all
players was 26.2 years (range, 19–35), median weightTable 2 Genotypic frequencies in the present study and for W
Hispanic (HISP1) populations in NCBI dbSNP
Gene Genotype Population
Total White
Present study Present study HapMap
N = 73 N = 43 CEU
ELN AA 27.40% 14% 15.50%
AG 56.20% 65.10% 65.11%
GG 16.40% 20.90% 36.40%
TTN AA 50.70% 58.10% 68.10%
AG 39.70% 37.20% 26.50%
GG 9.60% 4.70% 5.30%
SOX15 TT 58.90% 62.80% 58.40%
TG 31.50% 32.60% 33.60%
GG 9.60% 4.70% 8.00%
IGF2 GG 38.40% 30.20% 30.10%
GC 43.80% 53.50% 53.10%
CC 17.80% 16.30% 16.80%
CCL2 GG 43.80% 39.50% 65.20%
GC 46.60% 48.80% 30.40%
CC 9.60% 11.60% 4.03%
TNC AA 35.60% 30.20% 31.70%
AT 43.80% 51.20% 53.30%
TT 20.50% 18.60% 15.00%
COL1A1 GG 71.20% 72.10% -
GA 26% 23.30% 100%
AA 2.70% 4.65% -
COL5A1 TT - - 24.50%
TC 65.30% 76.20% 64.20%
CC 34.70% 23.80% 11.30%
P value refer to the differences in genotypic frequencies between ethnic groups in
N/A: data not available.was 75.6 kilos (range, 64–92), median height was 1.79
meters (range, 1.66-1.95), and median work load was
16027 minutes per year (267 hours/season/player)
(range, 15301–16544), with no significant differences
between ethnic groups for any of these characteristics.
Over the course of the three seasons of the study, a
total of 242 NCMSTIs were recorded for all 73 players.
Two hundred and three were muscle injuries, of which
129 (63.5%) were mild, 69 (34%) moderate, and 5 (2.5%)
severe. Twenty-four were ligament injuries, of which 15
(62.5%) were mild, 3 (12.5%) moderate, and 6 (25%) se-
vere. Fifteen were tendon injuries, of which 7 (46.7%)
were mild, 7 (46.7%) moderate, and 1 (6.6%) severe.
Allele frequencies, degree of injury and recovery time
Table 2 shows the allele frequencies of the eight genes,
both for the present study and according to the NCBIHITE (HapMap CEU), Black African (HapMap YRI) and
p-value
Black African Hispanic
Present study HapMap Present study HapMap
N = 11 YRI N = 19 HISP1
45.45% 40.20% 47.40% n/a <0.0001
36.40% 44.20% 47.40% n/a
18.20% 15.20% 5.20% n/a
27.30% 14.20% 47.40% n/a <0.0001
45.50% 46.90% 42.10% n/a
27.30% 38.90% 10.50% n/a
36.40% 20.40% 63.20% 52.20% <0.0001
36.40% 49.60% 26.30% 34.80%
27.30% 30.10% 10.50% 13.00%
45.45% 38.10% 52.60% 43.50% <0.0001
27.30% 42.30% 31.60% 21.70%
27.30% 9.20% 15.80% 34.80%
54.50% 52.20% 47.40% n/a <0.0001
45.50% 34.80% 42.10% n/a
- 13% 10.50% n/a
45.45% 46.70% 42.10% n/a <0.0001
36.40% 41.70% 31.60% n/a
18.20% 11.70% 26.30% n/a
81.80% 100% 63.20% n/a <0.0001
18.20% - 36.80% n/a
- - - n/a
- - - n/a <0.0001
18.20% 27.10% 68.40% n/a
81.80% 72.90% 31.60% n/a
the present study.
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three sub-groups in the present study (p < 0.0001).
Table 3 shows the association between SNPs and in-
jured structure. SNPs in IGF2 and CCL2 were associated
with the severity of muscle injuries. The 93 muscle injur-
ies associated with the IGF2 GC genotype were signifi-
cantly less severe than those associated with the IGF2
CC or GG genotypes (p = 0.034) (Figure 1A, Table 3).
The CCL2 genotypes CC and CG were also associated
with less severe muscle injuries than the CCL2 GG
genotype (p = 0.026) (Figure 1B, Table 3). Finally, the
COL5A1 TC genotype showed a tendency towards an
association with more severe muscle injuries (p = 0.08))
(Figure 1C, Table 3).
The 10 ligament injuries associated with the ELN AA
genotype were more severe than those associated with
the ELN AG or GG genotypes (p = 0.009) (Figure 2A,
Table 3). SNPs in ELN also showed evidence of a statisti-
cally significant association with recovery time. Injuries
associated with the ELN AG genotype required a shorter
mean recovery time (24.7days) than those associated
with the ELN GG (37.5 days) or AA (83.2 days) geno-
types (p = 0.043) (Figure 2B, Table 3).
There was no evidence of a statistically significant as-
sociation between the SNPs considered in the present
study and tendon injuries (see Additional file 1).
Discussion
The prevention, diagnosis and management treatment of
NCSMTIs are crucial in both professional and amateur
sports [34]. NCSMTIs occur as a consequence of extrin-
sic and intrinsic factors. The extrinsic factors that may
influence a soccer player’s predisposition to injury are
the design of the playing field, [35,36] the characteristics
of the ball, [36,37] air temperature, [36,38] altitude,





Muscle IGF2 GG 52 (70.3%)
GC 54 (58.1%)
CC 23 (63.9%)





Ligament ELN AA 5 (50%)
AG 10 (83.3%)
GG 0 (0%)factors that are considered risk factors for NCSMTIs are
age, [36,41,42] sex [36,43,44] and prior injuries [36,45].
Despite rigorous controls over many extrinsic and in-
trinsic factors, a wide range of interindividual differences
exists in number and degree of injuries and in recovery
time, [46] suggesting that other factors, including genetic
variations, [1-3] may exert an important influence on
these differences.
The frequency of specific SNPs varies between differ-
ent ethnic groups [47,48]. In the present study, we found
significant differences in the frequency of all the SNPs
among the three ethnic groups studied. Given these
findings, it would be interesting to further investigate
the relationship between ethnic differences and a player’s
predisposition to injury and recovery time.
In the present investigation, muscle injuries were the
most frequent ailments [5,49]. The degree of muscle in-
jury was related to SNPs in the IGF2 (p = 0.034) and
CCL2 (p = 0.026) genes, but not with COL5A1 (p =
0.08). Individuals with the IGF2 GC genotype experi-
enced less severe injuries than those with the homozy-
gous GG or CC genotypes (Table 3). Previous studies
report that IGFs play a role in soft tissues growth, and
increase their expression in response to degeneration
and regeneration following an injury, when IGFs work
with other genes, such as fibroblastic growth factor,
interleukin 1β, interleukin 6, and transforming growth
factor-β, to influence satellite cell activation [50-52].
Individuals with the CCL2 GG genotype suffered more
severe injuries than those with the CC or CG genotypes
(Table 3). CCL2 is a small chemokine produced by both
macrophages and satellite cells, [53] and plays key roles
in inflammation and immunoregulation [27]. CCL2 ex-
pression increases dramatically following muscle dam-
age, and recent data suggest that it plays significant roles
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Figure 1 Relation between muscle injuries and degree. Association of IGF2, CCL2 and COL5A1 to degree of muscle injury. A) Individuals with
the heterozygous variant of IGF2 suffered less severe injuries. B) Carriers of the CCL2 C allele experienced less severe injuries. C) Carriers of the
COL5A1 T allele showed a tendency towards more severe injuries (see Table 3).
Pruna et al. BMC Musculoskeletal Disorders 2013, 14:221 Page 5 of 7
http://www.biomedcentral.com/1471-2474/14/221SNPs in CCL2 have been related to markers of muscle
injury, such as creatine kinase and myoglobin levels and
muscle pain [27].
Individuals with the COL5A1 CC genotype showed a
tendency towards less severe muscle injuries than those
with the TC genotype (Table 3). COL5A1 encodes the α1
chain of collagen type V, which forms part of the extracel-
lular matrix of the skeletal muscles [54]. These COL5A1
molecules connect with collagen type I fibers in non-
cartilage connective tissue, modulating fibrillogenesis.














Figure 2 ELN related to ligament injuries. Relation of ELN with degree o
more severe injuries (see Table 3). B) Carriers of the G allele exhibited hadmust be present [55]. This is particularly evident in studies
of tendinopathy, where the presence of the C allele has
been associated with asymptomatic patients [12,56].
Although dealing with extremely high qualification ath-
letes, we acknowledge that the size of our cohort is
relatively small, and our results should be therefore
interpreted with caution. Nevertheless, the SNPs identified
in the ELN gene showed a significant statistical association
with the degree of ligament injuries (p = 0.009) and with
recovery time (p = 0.043). ELN, a self-assembling extracel-
lular matrix protein, is the major source of tissue elasticityp=0.043
f injury and recovery time. A) Individuals without the G allele suffered
faster recovery times.
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severe injuries and longer recovery times than those with
the AG or the GG genotypes (Table 3). A previous study
evaluating the relationship of the ELN SNP with age and
arterial compliance in 320 individuals with no symptoms
of cardiovascular disease and who had not received medi-
cations found that carriers of the A allele had decreased
arterial compliance compared to those with the homozy-
gous GG variant [58]. The shorter recovery time observed
in the present study for carriers of the G allele may be re-
lated to a more efficient elastin function, since altered
elastin affects elastogenesis and the function of elastic fi-
bers in vivo [23].
Conclusions
The genetic profile based on the study of SNPs consti-
tutes a novel field of investigation in sports medicine
and may help to identify individuals with a shorter re-
covery time and greater response to treatment and those
at a greater risk of injury [29]. Since the study of genetic
profiles in sports medicine is still in its early stages, fur-
ther studies with larger samples are warranted to valid-
ate our findings.
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